Zika Prevention Strategies: Patient & Community Health

DATE: May 25, 2016, 4:00 p.m. EDT  /  LENGTH: 60 minutes


Jeffrey Bratberg, PharmD, BCPS, Clinical Professor of Pharmacy Practice
University of Rhode Island College of Pharmacy

Paul E. Jarris, MD, MBA, Senior Vice President Maternal Child Health
March of Dimes Foundation

Zika virus, spread primarily through the bite of an infected mosquito, is a growing health threat to people living in, or traveling to, affected areas including Puerto Rico, American Samoa and the U.S. Virgin Islands. Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Rare but serious neurological conditions like Guillain-Barré syndrome are also seen at much higher rates in those infected with Zika. Currently, there is no vaccine available for Zika virus. Health officials focus on prevention strategies that target mosquito bite prevention and avoidance of exposure. This webinar offers community-based pharmacists information on the Zika Virus and discusses prevention measures, community surveillance and effective prevention patient counseling.

UAN: 0206-0000-16-001-L04-P (0.1 CEUs)

Select “Register” in order to receive the webinar information and calendar invite. This webinar and the CE credit is open to all interested parties and provided by the NACDS Foundation. Space is limited to the first 125 registrants. One hour of live CE credit will be available for this ACPE accredited program following the directions indicated on the Learner Community site.


Target Audience

This course is for pharmacists; especially for those in high risk areas of the Zika virus.

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Describe what the Zika virus is, how the virus is transmitted, and who is at risk of being infected.
  • List the symptoms and risks of Zika virus infection.
  • Describe the risk of adverse pregnancy or birth outcomes for women infected with Zika and the risk of serious neurological diseases associated with Zika virus exposure.
  • Recognize and explain the implications related to sexual transmission of the Zika virus.
  • Identify effective methods for prevention of infection and transmission of the Zika virus.
  • Describe how pharmacists can use motivational counseling related to Zika prevention.

The National Association of Chain Drug Stores is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Zika Prevention ACPE Universal Activity #0206-0000-16-001-L04-P. Initial Release Date: 05/25/2015